ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Educational Symposium

More Options and More to Come: Update on the Management of Lupus Nephritis

November 04, 2021 | 12:45 PM - 01:45 PM

Location: Simulive, Virtual Only

Session Description

Kidney diseases are clinically evident in up to 50% of patients with systemic lupus erythematosus. Up to 10% of patients with lupus nephritis (LN) progress toward ESKD. There have been recent advances in the understanding of disease pathogenesis, classification, biomarker identification, and therapeutic drug development for LN, although their impact on long-term clinical outcomes is unclear.

This symposium reviews the pathogenesis, classification, and treatment of LN. Emerging therapeutic targets and treatment options are discussed.

Support is provided by an educational grant from GlaxoSmithKline.

Learning Objective(s)

  • Describe the diagnosis, classification, and pathogenesis of LN
  • Discuss the mechanisms of action and clinical utility of emerging and recently approved therapies for LN

Learning Pathway(s)

  • Glomerular Diseases


  • Andrew S. Bomback, MD, MPH


  • Introduction
    12:45 PM - 12:55 PM
    Andrew S. Bomback, MD, MPH
  • Pathogenesis, Diagnosis, and Surveillance of Lupus Nephritis
    12:55 PM - 01:20 PM
    Samir V. Parikh, MD, FASN
  • Treatment of Lupus Nephritis
    01:20 PM - 01:45 PM
    Brad H. Rovin, MD, FASN